Open Label Study of Fostamatinib in the Treatment of IgA Nephropathy
Clinical trial NCT02433236 · WITHDRAWN
Trial details
- NCT number
- NCT02433236
- Sponsor
- Rigel Pharmaceuticals
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-09-01
- Primary completion
- 2015-09-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.